News & Analysis on Clinical Trial Services & Contract Research And Development
Bayer Schering Pharma this week announced that it has scrapped plans to introduce a double-dose version of its top-selling multiple sclerosis (MS) drug Betaferon (interferon beta-1b) by the end of the year following disappointing trial results from...
Japanese pharma firm Takeda beat off strong competition from the likes of Coca-Cola to take home the dubious honour of Consumer International's 'Worst Product' award thanks to its sleeping pill ad.
Summit (formerly VASTox) has signed a $450,000 (€312,000) deal with one of the world's top five pharma firms to enable it to use Summit's zebrafish-platform in its drug safety programme.
Thermo Fisher Scientific saw revenues for the third quarter of 2007 rise to $2.4bn (€1.7bn) with its Analytical Technologies division growing 12 per cent with quarterly sales of $1.04bn.
Outsourcing-Pharma.com special focus
Sanofi-Aventis has had to take Inyx USA to court after it failed to deliver on a contract manufacturing and supply agreement, a situation that Aventis feared could "seriously harm its interests". There may be important lessons to be learned for all...
Applied Biosystems (ABI) saw 5 per cent revenue growth during its first quarter of fiscal 2008 as sister company Celera posted revenue growth of 57 per cent.
Thermo Fisher Scientific continues to fish for new opportunities in India and has begun setting up a new clinical services base in the country.
Two pharmaceutical companies have faced explosions at their plants in the last week, local media reported.